Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization

BackgroundSphingolipids are components of cell membrane structure, but also circulate in serum and are essential mediators of many cellular functions. While ceramides have been proposed previously as a useful biomarker for cardiometabolic disease, the involvement of other sphingolipids is still cont...

Full description

Bibliographic Details
Main Authors: Loni Berkowitz, Cristian Salazar, Carol D. Ryff, Christopher L. Coe, Attilio Rigotti
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1092331/full